These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 20602797)
61. Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells. Matsuhashi S; Hamajima H; Xia J; Zhang H; Mizuta T; Anzai K; Ozaki I Cell Signal; 2014 Mar; 26(3):603-10. PubMed ID: 24334270 [TBL] [Abstract][Full Text] [Related]
62. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma. Zhou J; Li W; Guo J; Li G; Chen F; Zhou J Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956 [TBL] [Abstract][Full Text] [Related]
63. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma. Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663 [TBL] [Abstract][Full Text] [Related]
64. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1). Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250 [TBL] [Abstract][Full Text] [Related]
65. miR-589-5p inhibits MAP3K8 and suppresses CD90 Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990 [TBL] [Abstract][Full Text] [Related]
66. MiR-384 regulated IRS1 expression and suppressed cell proliferation of human hepatocellular carcinoma. Lai YY; Shen F; Cai WS; Chen JW; Feng JH; Cao J; Xiao HQ; Zhu GH; Xu B Tumour Biol; 2016 Oct; 37(10):14165-14171. PubMed ID: 27542674 [TBL] [Abstract][Full Text] [Related]
67. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression. Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061 [TBL] [Abstract][Full Text] [Related]
68. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939 [TBL] [Abstract][Full Text] [Related]
69. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway. Bai Z; Xia X; Lu J Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177 [TBL] [Abstract][Full Text] [Related]
70. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772 [TBL] [Abstract][Full Text] [Related]
71. Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma. Wang YC; Chen YL; Yuan RH; Pan HW; Yang WC; Hsu HC; Jeng YM Carcinogenesis; 2010 Sep; 31(9):1516-22. PubMed ID: 20525879 [TBL] [Abstract][Full Text] [Related]
72. Effects of miR-340 on hepatocellular carcinoma by targeting the DcR3 gene. Xie L; Chen Z; Liu H; Guan L; Wang Z; Li W Dig Liver Dis; 2018 Mar; 50(3):291-296. PubMed ID: 29311025 [TBL] [Abstract][Full Text] [Related]
73. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766 [TBL] [Abstract][Full Text] [Related]
74. Long non-coding RNA LINC00472 suppresses hepatocellular carcinoma cell proliferation, migration and invasion through miR-93-5p/PDCD4 pathway. Chen C; Zheng Q; Kang W; Yu C Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):436-445. PubMed ID: 30522853 [TBL] [Abstract][Full Text] [Related]
75. miR-922 regulates CYLD expression and promotes the cell proliferation of human hepatocellular carcinoma. Liu J; Su Z; Zeng Y; Zhang H; Yang S; Liu G Oncol Rep; 2017 Mar; 37(3):1445-1450. PubMed ID: 28184924 [TBL] [Abstract][Full Text] [Related]
76. Circ-HOMER1 enhances the inhibition of miR-1322 on CXCL6 to regulate the growth and aggressiveness of hepatocellular carcinoma cells. Zhao M; Dong G; Meng Q; Lin S; Li X J Cell Biochem; 2020 Nov; 121(11):4440-4449. PubMed ID: 32037619 [TBL] [Abstract][Full Text] [Related]
77. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma. Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619 [TBL] [Abstract][Full Text] [Related]
78. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4). Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720 [TBL] [Abstract][Full Text] [Related]
79. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines. Gu J; Zhu X; Li Y; Dong D; Yao J; Lin C; Huang K; Hu H; Fei J Med Oncol; 2011 Mar; 28(1):211-8. PubMed ID: 20143188 [TBL] [Abstract][Full Text] [Related]
80. The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma. Zhang L; Niu H; Ma J; Yuan BY; Chen YH; Zhuang Y; Chen GW; Zeng ZC; Xiang ZL Mol Cancer; 2019 Jul; 18(1):120. PubMed ID: 31349837 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]